Resistance to Imatinib: Mechanisms and Management

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.3, Iss.6, 2005-11, pp. : 757-768

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of Resistance to Imatinib in CML Patients: A Paradigm for the Advantages and Pitfalls of Molecularly Targeted Therapy

Current Cancer Drug Targets, Vol. 6, Iss. 8, 2006-12 ,pp. : 645-657

Bentham Science Publishers

Access to resources Recommend Favorite

Imatinib (STI571) Resistance in Chronic Myelogenous Leukemia: Molecular Basis of the Underlying Mechanisms and Potential Strategies for Treatment

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 285-299

Bentham Science Publishers

Access to resources Recommend Favorite

Imatinib: Acquired resistance: case report

Reactions Weekly, Vol. 1, Iss. 1415, 2012-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite

Sunitinib gets the gist in imatinib-resistance

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Lonafarnib overcomes imatinib mesylate resistance

Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite